BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND GNAS, RP4-543J19_4, 2778, ENSG00000087460, NESP55, NESP, GSP, POH, GNASXL, GNAS1, C20orf45, dJ309F20_1_1, SCG6, GPSA, Gnas, dJ806M20_3_3, XL2, MGC33735, XL, PHP1A, GSA, AHO, XLalphas, PHP1B AND Treatment
27799 results:

  • 1. Immunotherapy for esophageal cancer: Where are we now and where can we go.
    Shoji Y; Koyanagi K; Kanamori K; Tajima K; Ogimi M; Ninomiya Y; Yamamoto M; Kazuno A; Nabeshima K; Nishi T; Mori M
    World J Gastroenterol; 2024 May; 30(19):2496-2501. PubMed ID: 38817664
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical, histopathological characteristics and malignant transformation of proliferative verrucous leukoplakia with 36 patients: a retrospective longitudinal study.
    Zhang C; Lan Q; Wei P; Gao Y; Zhang J; Hua H
    BMC Oral Health; 2024 May; 24(1):639. PubMed ID: 38816724
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Salvage radiofrequency ablation followed by external beam radiotherapy for inoperable recurrent differentiated thyroid cancer.
    Chen CS; Luo SD; Chang YH; Chou CK; Chi SY; Wu SC; Chen YH; Yang JC; Huang EY; Wang YM; Lin WC
    Int J Hyperthermia; 2024; 41(1):2358054. PubMed ID: 38816274
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Interactions between LAMP3+ dendritic cells and T-cell subpopulations promote immune evasion in papillary thyroid carcinoma.
    Wang Z; Ji X; Zhang Y; Yang F; Su H; Zhang H; Li Z; Zhang W; Sun W
    J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38816233
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Immune checkpoint inhibitors as the second-line treatment for advanced esophageal squamous cell carcinoma: a cost-effectiveness analysis based on network meta-analysis.
    Yang X; Zheng X; Hu S; Huang J; Zhang M; Huang P; Wang J
    BMC Cancer; 2024 May; 24(1):654. PubMed ID: 38811891
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Practical surgical technique using the SMISS approach for lip reduction in involuted lip infantile hemangiomas.
    Chen Q; Chang SJ; Gao W; Chang L; Qiu Y; Lin X
    BMC Pediatr; 2024 May; 24(1):368. PubMed ID: 38807073
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study.
    Kornfeld B; Taha A; Kyang L; Sim HW; Dewhurst S; McCloy R; Chin V; Earls P; Parker A; Leavers B; Forstner D; Floros P; Crawford J; Gallagher R
    J Robot Surg; 2024 May; 18(1):226. PubMed ID: 38806847
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comprehensive analysis revealed P4Hs as new biomarkers for prognosis and immunotherapy in head and neck cancer.
    Zhou H; Lei Y; Luo J; Wang J; Peng L; Mou K; Xiang L; Luo Y
    Sci Rep; 2024 May; 14(1):12234. PubMed ID: 38806556
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Donafenib as neoadjuvant therapy in locally advanced thyroid cancer: protocol for the DONATHYCA phase II prospective single-arm trial in China.
    Yu J; Liu H; Wu Y
    BMJ Open; 2024 May; 14(5):e081090. PubMed ID: 38806431
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial.
    Qiu MZ; Oh DY; Kato K; Arkenau T; Tabernero J; Correa MC; Zimina AV; Bai Y; Shi J; Lee KW; Wang J; Poddubskaya E; Pan H; Rha SY; Zhang R; Hirano H; Spigel D; Yamaguchi K; Chao Y; Wyrwicz L; Disel U; Cid RP; Fornaro L; Evesque L; Wang H; Xu Y; Li J; Sheng T; Yang S; Li L; Moehler M; Xu RH;
    BMJ; 2024 May; 385():e078876. PubMed ID: 38806195
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Our experience in the treatment of congenital nasal median heterotopias in children and an overview of various treatment tactics].
    Molodtsova EV; Yunusov AS; Daikhes NA; Polyakov DP; Korobkin AS; Larina OM
    Vestn Otorinolaringol; 2024; 89(2):28-32. PubMed ID: 38805460
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. cancer-associated stroke from progressive acinic cell carcinoma.
    Garcia JJB; Pascual JLV
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38789271
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Predictive role of Naples prognostic score for survival in esophageal cancer: A meta-analysis.
    Guo H; Wang T
    Medicine (Baltimore); 2024 May; 103(21):e38160. PubMed ID: 38787991
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Efficacy and safety of eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with anthracycline/taxanes.
    Chen L; Yan X; Luo T; Tian T; He P; Zhong X
    Cancer Med; 2024 May; 13(10):e7295. PubMed ID: 38785215
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Systematic evaluation and meta-analysis of the prognosis of down-staging human papillomavirus (HPV) positive oropharyngeal squamous cell carcinoma using cetuximab combined with radiotherapy instead of cisplatin combined with radiotherapy.
    Hu Q; Li F; Yang K
    PeerJ; 2024; 12():e17391. PubMed ID: 38784388
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prevalence of human papillomavirus in head and neck cancer patients in India: a systematic review and meta-analysis.
    Satapathy P; Khatib MN; Gaidhane S; Zahiruddin QS; Serhan HA; Sharma RK; Sharma D; Arora M; Rustagi S; Na A; Alsayyah A; Al-Hajeili M; Al-Subaie MF; Alfaresi M; Alissa M; Rabaan AA
    BMC Infect Dis; 2024 May; 24(1):516. PubMed ID: 38783184
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Feasibility analysis of the application of programmed process endoscopic lateral neck dissection via chest-breast approach in papillary thyroid carcinoma surgery].
    Xu N; Li ZY; Luo XP; Gao HY; Huang JF; Wang YY; Liu XJ; Xu B
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1831-1836. PubMed ID: 38782751
    [No Abstract]    [Full Text] [Related]  

  • 18. Intronic miR-6741-3p targets the oncogene SRSF3: Implications for oral squamous cell carcinoma pathogenesis.
    More DA; Singh N; Mishra R; Muralidharan HP; Gopinath KS; Gopal C; Kumar A
    PLoS One; 2024; 19(5):e0296565. PubMed ID: 38781195
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Circulating tumour cells predict recurrences and survival in head and neck squamous cell carcinoma patients.
    Zhang X; Weeramange CE; Hughes BGM; Vasani S; Liu ZY; Warkiani M; Hartel G; Ladwa R; Thiery JP; Kenny L; Breik O; Punyadeera C
    Cell Mol Life Sci; 2024 May; 81(1):233. PubMed ID: 38780775
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A Combination of Curcumin and
    Udompatanakorn C; Ratthawongjirakul P
    J Evid Based Integr Med; 2024; 29():2515690X241258369. PubMed ID: 38778767
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1390.